EligibleTrials

Study of the Role of Genetic Modifiers in Hemoglobinopathies

Recruiting · NCT05799118 · Observational (researchers observe without assigning treatment) · Lead sponsor: Cyprus Institute of Neurology and Genetics

View the official record on ClinicalTrials.gov →
Sickle Cell Disease

Interventions studied

GWAS

What this trial is about

This study will investigate the role of genetic modifiers in hemoglobinopathies through a large-scale, multi-ethnic genome-wide association study (GWAS).

Who can take part

Age range
2 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)

Inclusion criteria

Exclusion criteria

Where it is running

26 locations listed across 1 US state.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.